Skip to main content
. Author manuscript; available in PMC: 2023 Jun 29.
Published in final edited form as: Nat Med. 2022 Mar 21;28(4):724–734. doi: 10.1038/s41591-022-01726-1

Extended Data Fig. 4. Longitudinal cytokine, chemokine and growth factor profiles in the peripheral blood of mCRPC patients treated with CART-PSMA-TGFβRDN cells.

Extended Data Fig. 4

Fold changes in serum cytokine, chemokine and growth factor levels from baseline (preCAR T cell infusion) to each time point postCART-PSMA-TGFβRDN cell administration were measured in patients by multiplex analysis and are depicted as line graphs.

HHS Vulnerability Disclosure